These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18273760)

  • 21. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study.
    Rogowski WH
    Med Decis Making; 2009; 29(2):224-38. PubMed ID: 19182214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
    Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
    Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
    van Gils P; van den Berg M; van Kranen H; de Wit AG
    Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
    Lamotte M; Annemans L; Kawalec P; Zoellners Y
    Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cost-effectiveness of screening for amblyopia].
    Neubauer AS; Neubauer S
    Klin Monbl Augenheilkd; 2005 Feb; 222(2):110-6. PubMed ID: 15719314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands.
    Postma MJ; van Hulst M; De Wolf JT; Botteman M; Staginnus U
    Transfus Med; 2005 Oct; 15(5):379-87. PubMed ID: 16202052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of defunctioning stomas in low anterior resections for rectal cancer: a call for benchmarking.
    Koperna T
    Arch Surg; 2003 Dec; 138(12):1334-8; discussion 1339. PubMed ID: 14662534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness of community-based physical activity interventions.
    Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
    Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy.
    Ingles J; McGaughran J; Scuffham PA; Atherton J; Semsarian C
    Heart; 2012 Apr; 98(8):625-30. PubMed ID: 22128210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of a test to detect metastases for endometrial cancer.
    Havrilesky LJ; Maxwell GL; Chan JK; Myers ER
    Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cost-effectiveness analysis of a genetic screening program in the close relatives of Spanish patients with familial hypercholesterolemia].
    Oliva J; López-Bastida J; Moreno SG; Mata P; Alonso R
    Rev Esp Cardiol; 2009 Jan; 62(1):57-65. PubMed ID: 19150015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-saving analysis of screening colonoscopy in Germany.
    Sieg A; Brenner H
    Z Gastroenterol; 2007 Sep; 45(9):945-51. PubMed ID: 17874356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
    Anderson R; Haas M; Shanahan M
    Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs and cost-effectiveness of colorectal cancer prevention and therapy.
    Schrag D; Weeks J
    Semin Oncol; 1999 Oct; 26(5):561-8. PubMed ID: 10528905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost of care of colorectal cancers according to health care patterns and stage at diagnosis in France.
    Clerc L; Jooste V; Lejeune C; Schmitt B; Arveux P; Quantin C; Faivre J; Bouvier AM
    Eur J Health Econ; 2008 Nov; 9(4):361-7. PubMed ID: 18030510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Refractive benefit and incremental costs of LASIK: results of a cost benefit study in two universities' LASIK departments].
    Krummenauer F; Roden M; Knorz MC; Dick HB
    Klin Monbl Augenheilkd; 2003 May; 220(5):320-5. PubMed ID: 12766820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of screening strategies for Gonorrhea among females in private sector care.
    Bernstein KT; Mehta SD; Rompalo AM; Erbelding EJ
    Obstet Gynecol; 2006 Apr; 107(4):813-21. PubMed ID: 16582117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.